172 related articles for article (PubMed ID: 38001509)
21. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Winn A; Zarei P; O'Grady M; Huang ES
Diabetes Care; 2018 Jun; 41(6):1227-1234. PubMed ID: 29650803
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain.
Conget I; Martín-Vaquero P; Roze S; Elías I; Pineda C; Álvarez M; Delbaere A; Ampudia-Blasco FJ
Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(7):380-386. PubMed ID: 29789227
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Cost-Effectiveness of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Adults With Type 1 Diabetes in Iran.
Molaee MC; Naseri ZG; Karami MA
Value Health Reg Issues; 2024 May; 43():101002. PubMed ID: 38820700
[TBL] [Abstract][Full Text] [Related]
24. Frequency of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Using FreeStyle Libre: A Retrospective Chart Review.
Al Hayek AA; Al Dawish MA
Adv Ther; 2021 Jun; 38(6):3314-3324. PubMed ID: 34009604
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of FreeStyle Libre in pediatric t1dm: improved glycemic control, reduction in diabetic ketoacidosis and severe hypoglycemia].
Laptev DN; Bezlepkina OB; Demina ES; Malievskiy OA; Nikitina IL; Samoilova IG; Peterkova VA
Probl Endokrinol (Mosk); 2022 Feb; 68(3):86-92. PubMed ID: 35841172
[TBL] [Abstract][Full Text] [Related]
26. Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France.
Guerci B; Roussel R; Levrat-Guillen F; Detournay B; Vicaut E; De Pouvourville G; Emery C; Riveline JP
Diabetes Technol Ther; 2023 Jan; 25(1):20-30. PubMed ID: 36094418
[No Abstract] [Full Text] [Related]
27. Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia.
Lalić N; Russel-Szymczyk M; Culic M; Tikkanen CK; Chubb B
Diabetes Ther; 2018 Jun; 9(3):1201-1216. PubMed ID: 29700772
[TBL] [Abstract][Full Text] [Related]
28. Cost Analysis of FreeStyle Libre
Oyagüez I; Gómez-Peralta F; Artola S; Carrasco FJ; Carretero-Gómez J; García-Soidan J; Gómez-Huelgas R; Merino-Torres JF; Pérez A
Diabetes Ther; 2021 Sep; 12(9):2329-2342. PubMed ID: 33948909
[TBL] [Abstract][Full Text] [Related]
29. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC).
Herman WH; Braffett BH; Kuo S; Lee JM; Brandle M; Jacobson AM; Prosser LA; Lachin JM
J Diabetes Complications; 2018 Oct; 32(10):934-939. PubMed ID: 30064713
[TBL] [Abstract][Full Text] [Related]
30. Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study.
Rotondi MA; Wong O; Riddell M; Perkins B
Diabetes Care; 2022 Sep; 45(9):2012-2019. PubMed ID: 35834175
[TBL] [Abstract][Full Text] [Related]
31. Reduced rate of hospitalizations for acute diabetes events before and after FreeStyle Libre® system initiation in some people with type 2 diabetes on insulin-secretagogue oral drug therapy without insulin in France.
Riveline JP; Levrat-Guillen F; Detournay B; Vicaut E; de Pouvourville G; Emery C; Guerci B
Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38885325
[TBL] [Abstract][Full Text] [Related]
32. Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5).
Lameijer A; Fokkert MJ; Edens MA; Slingerland RJ; Bilo HJG; van Dijk PR
J Clin Transl Endocrinol; 2020 Dec; 22():100237. PubMed ID: 33102135
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada.
Roze S; Isitt JJ; Smith-Palmer J; Lynch P
Clinicoecon Outcomes Res; 2021; 13():717-725. PubMed ID: 34408456
[TBL] [Abstract][Full Text] [Related]
34. Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US.
Tunis SL; Minshall ME
Curr Med Res Opin; 2010 Jan; 26(1):151-62. PubMed ID: 19919376
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria.
Russel-Szymczyk M; Valov V; Savova A; Manova M
BMC Endocr Disord; 2019 Dec; 19(1):132. PubMed ID: 31796048
[TBL] [Abstract][Full Text] [Related]
36. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes.
Huang ES; O'Grady M; Basu A; Winn A; John P; Lee J; Meltzer D; Kollman C; Laffel L; Tamborlane W; Weinzimer S; Wysocki T;
Diabetes Care; 2010 Jun; 33(6):1269-74. PubMed ID: 20332354
[TBL] [Abstract][Full Text] [Related]
37. FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis.
Blissett R; Blissett D; Levrat-Guillen F; Deshmukh H; Wilmot EG; Ryder REJ; Walton C; Sathyapalan T
BMJ Open Diabetes Res Care; 2022 Mar; 10(2):. PubMed ID: 35346970
[TBL] [Abstract][Full Text] [Related]
38. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
[TBL] [Abstract][Full Text] [Related]
39. Cost-Effectiveness of a Continuous Glucose Monitoring Mobile App for Patients With Type 2 Diabetes Mellitus: Analysis Simulation.
Tsuji S; Ishikawa T; Morii Y; Zhang H; Suzuki T; Tanikawa T; Nakaya J; Ogasawara K
J Med Internet Res; 2020 Sep; 22(9):e16053. PubMed ID: 32940613
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes.
McQueen RB; Ellis SL; Campbell JD; Nair KV; Sullivan PW
Cost Eff Resour Alloc; 2011 Sep; 9():13. PubMed ID: 21917132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
